Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) · IgA Nephropathy (IgAN) · VERA

Vera Therapeutics

Vera Therapeutics trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
4539 Metropolitan Ct, Frederick, Maryland 21704, US HQ
2018 Founded
9 Employees
Public company Type
VERA · NYSE Ticker
Company details
Status
Public
HQ
4539 Metropolitan Ct, Frederick, Maryland 21704, US
Founded
2018
Employees
9
Programs
25
Drugs
32
Patents
140
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Vera Therapeutics clinical trials

Registry index of 25 ClinicalTrials.gov studies linked to Vera Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Vera Therapeutics trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Vera Therapeutics.

  1. VS-6766-301 — Phase 3

    Clinical update

  2. Remifentanil — Unknown

    Clinical update

  3. Pregabalin — Approved

    Clinical update

  4. Peginterferon alfa-2a — Approved

    Clinical update

  5. P2Y12 antagonist monotherapy — Unknown

    Clinical update

  6. Herzuma — Phase 2

    Clinical update

  7. Nitazoxanide Tablets — Unknown

    Clinical update

  8. Immune Globulin 10% Intravenous Solution — Phase 3

    Clinical update

Trial registry

25 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.